Review
Open access
Aug 2026
Treatment of anti-GAD65 antibody-positive epilepsy and cerebellar ataxia with efgartigimod: a case report and literature review
This case demonstrates that anti-GAD65 antibody syndrome can present as concurrent refractory epilepsy and cerebellar ataxia, and the sequential regimen of efgartigimod induction combined with mycophenolate mofetil maintenance appears effective and safe.
Lu-Lu Xie, Junqin Zuo, Le Luo et al.
· Frontiers in Immunology · 0 citations